- Home
- CMPR vs BCRX Comparison
CMPR vs BCRX Comparison
Compare CMPR & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMPR
- BCRX
- Stock Information
- Founded
- CMPR 1994
- BCRX 1986
- Country
- CMPR Ireland
- BCRX United States
- Employees
- CMPR N/A
- BCRX N/A
- Industry
- CMPR Publishing
- BCRX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CMPR Consumer Discretionary
- BCRX Health Care
- Exchange
- CMPR Nasdaq
- BCRX Nasdaq
- Market Cap
- CMPR 1.6B
- BCRX 1.4B
- IPO Year
- CMPR N/A
- BCRX 1994
- Fundamental
- Price
- CMPR $65.99
- BCRX $7.22
- Analyst Decision
- CMPR Strong Buy
- BCRX Strong Buy
- Analyst Count
- CMPR 2
- BCRX 11
- Target Price
- CMPR $77.50
- BCRX $19.00
- AVG Volume (30 Days)
- CMPR 192.0K
- BCRX 5.7M
- Earning Date
- CMPR 10-29-2025
- BCRX 11-03-2025
- Dividend Yield
- CMPR N/A
- BCRX N/A
- EPS Growth
- CMPR N/A
- BCRX N/A
- EPS
- CMPR 1.37
- BCRX N/A
- Revenue
- CMPR $3,461,387,000.00
- BCRX $599,816,000.00
- Revenue This Year
- CMPR $7.87
- BCRX $41.57
- Revenue Next Year
- CMPR $4.82
- BCRX $6.25
- P/E Ratio
- CMPR $48.27
- BCRX N/A
- Revenue Growth
- CMPR 3.65
- BCRX 45.38
- 52 Week Low
- CMPR $35.21
- BCRX $6.00
- 52 Week High
- CMPR $85.56
- BCRX $11.31
- Technical
- Relative Strength Index (RSI)
- CMPR 49.94
- BCRX 49.59
- Support Level
- CMPR $60.59
- BCRX $6.84
- Resistance Level
- CMPR $76.65
- BCRX $7.33
- Average True Range (ATR)
- CMPR 4.30
- BCRX 0.26
- MACD
- CMPR -0.45
- BCRX 0.04
- Stochastic Oscillator
- CMPR 27.90
- BCRX 68.75
About CMPR Cimpress plc (Ireland)
Cimpress PLC invests in and builds customer-focused, entrepreneurial, mass-customization businesses for the long term. Mass customization seeks to produce goods and services to meet individual customer needs with near mass production efficiency. Its products and services include a broad range of marketing materials, business cards, signage, promotional products, logo apparel, packaging, books and magazines, wall decor, photo merchandise, invitations and announcements, design and digital marketing services, and other categories. The company's segment includes Vista; PrintBrothers; The Print Group; National Pen and All Other Businesses. It generates maximum revenue from the Vista segment.
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.